Stockscreener 앱 받기
5.76
4.35%
0.24
시간 외 거래:
5.80
0.04
+0.69%
전일 마감가:
$5.52
열려 있는:
$5.63
하루 거래량:
505.34K
Relative Volume:
1.41
시가총액:
$152.26M
수익:
$50.14M
순이익/손실:
$-35.38M
주가수익비율:
-4.1143
EPS:
-1.4
순현금흐름:
$-39.46M
1주 성능:
+7.46%
1개월 성능:
+1.05%
6개월 성능:
-34.40%
1년 성능:
-40.06%
1일 변동 폭
$5.63
$5.90
1주일 범위
$3.60
$5.90
52주 변동 폭
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
RCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.76 | 146.91M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-08 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
Wall Street Zen Downgrades Avita Medical (NASDAQ:RCEL) to Sell - MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Avita Medical: Equity Raise Derisks Runway to Positive Cash Flow - Morningstar
Analysts Are More Bearish On AVITA Medical, Inc. (NASDAQ:RCEL) Than They Used To Be - Yahoo Finance
Institutional Tools Highlight Unusual Flow in AVITA Medical Inc.2025 Support & Resistance & Safe Capital Growth Tips - 선데이타임즈
Avita Medical (NASDAQ:RCEL) Rating Lowered to "Sell" at BTIG Research - MarketBeat
Avita’s Road to Profitability Is in Sight - Morningstar
Avita Medical Raises $15M Through Australian Equity Placement - AInvest
Avita Medical says it completed Australian equity raise - MarketScreener
Avita Medical shares rise 3.44% after-hours after completing a private placement of approximately 17.2 million new CHESS Depositary Interests. - AInvest
Avita Medical (NASDAQ:RCEL) Price Target Cut to $18.00 by Analysts at D. Boral Capital - MarketBeat
Lake Street Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price - MarketBeat
AVITA Medical Successfully Completes Australian Equity Raise | RCEL Stock News - GuruFocus
AVITA Medical Successfully Completes Australian Equity Raise - The Manila Times
AVITA Medical Raises US$15M from Australian Investors to Fuel Growth Until Cash Flow Positive - Stock Titan
Evernest Financial Advisors LLC Buys New Position in Avita Medical Inc. (NASDAQ:RCEL) - MarketBeat
Dr. Michael Tarnoff - DOTmed
AVITA Medical: Lake Street maintains Buy, PT down to $8 from $14. - AInvest
Lake Street Capital Markets assumes coverage on Avita Medical stock with Buy rating - Investing.com Canada
Avita Medical shares rise 3.29% premarket after announcing an investor webinar briefing. - AInvest
Visualizing AVITA Medical Inc. stock with heatmapsShort-Term Swing Opportunity Summary Sheet - Newser
Avita Medical (NASDAQ:RCEL) Cut to Sell at BTIG Research - Defense World
What momentum shifts mean for AVITA Medical Inc.Real-Time Equity Price Action Analysis - Newser
Full technical analysis of AVITA Medical Inc. stockFree Investment Plan With Growth Optimization - Newser
AVITA Medical to Host Investor Webinar: Financial and Business Update - AInvest
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical CEO to Present Q2 Earnings Deep Dive: How to Join the Upcoming Investor Briefing - Stock Titan
AVITA Medical (RCEL.O) Suffers 21% Drop: A Technical and Order-Flow Deep Dive - AInvest
AVITA Medical, Inc. (NASDAQ:RCEL) Not Doing Enough For Some Investors As Its Shares Slump 25% - simplywall.st
Avita projects $76M–$81M 2025 revenue with rebound expected as claims backlog eases - MSN
Lower fair value for undervalued ASX share - Morningstar
Avita Medical Q2 2025 Revenue at $18.4M, Projects $76M-$81M 2025 Revenue with Backlog Easing - AInvest
AVITA Medical 2025 Q2 Earnings Narrowed Losses, Revenues Up but Guidance Cut - AInvest
Is AVITA Medical Inc. forming a bottoming baseBollinger Band Squeeze and Expansion Analysis - Newser
Orica Limited Updates on Share Buy-Back Progress - The Globe and Mail
Avita Medical shares rise 2.82% after-hours after revising earnings guidance for 2025. - AInvest
Avita Medical: Navigating Short-Term Reimbursement Headwinds, Unlocking Long-Term Growth in Acute Wound Care - AInvest
BTIG Downgrades Avita Medical(RCEL.US) to Sell Rating, Announces Target Price $3 - 富途牛牛
Form 424B5 AVITA Medical, Inc. - StreetInsider
BTIG Downgrades AVITA Medical to Sell From Neutral, Price Target is $3 - MarketScreener
Earnings call transcript: Avita Medical Q2 2025 reveals revenue miss, stock tumbles - Investing.com Canada
Avita Medical stock downgraded to Sell by BTIG on reimbursement issues - Investing.com Canada
AVITA Medical, Inc. SEC 10-Q Report - TradingView
Avita Medical shares fall 31.97% premarket after revising earnings guidance for 2025. - AInvest
Avita Medical Q2 2025 slides: revenue grows 21% but guidance slashed on reimbursement delays - Investing.com Canada
AVITA Medical Inc (AVHHL) Q2 2025 Earnings Call Highlights: Reve - GuruFocus
Avita Medical (RCEL) Q2 Sales Up 21% - AOL.com
Transcript : AVITA Medical, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
AVITA Medical Reports Q2 2025 Financial Results - TipRanks
Avita Medical (RCEL) Q2 Sales Up 21% - The Motley Fool
Guess which ASX All Ords stock just crashed 23% on earnings miss - The Motley Fool Australia
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.31%
1.36%
자본화:
|
볼륨(24시간):